BioSpace News Archive

Y-mAbs Therapeutics, Inc. announced that it has completed a positive Type B Pre-Biologics License Application meeting with the U.S. Food and Drug Administration regarding a potential pathway for FDA approval of omburtamab for the treatment of patients with CNS/leptomeningeal metastases from neuroblastoma.

BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, reported results for the quarter and year ended December 31, 2019.

REGENXBIO Inc., a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV Technology Platform, announced financial results for the fourth quarter and full year ended December 31, 2019, and recent operational highlights.

NanoString Technologies, Inc., a leading provider of life science tools for translational research, reported financial results for the fourth quarter and year ended December 31, 2019.

CONMED Corporation announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the Barclays Global Healthcare Conference at 10:15 a.m. ET on Tuesday, March 10, 2020 in Miami Beach, FL.

ACADIA Pharmaceuticals Inc. announced financial results for the fourth quarter and full year ended December 31, 2019.

Cutera, Inc., a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, reported financial results for the fourth quarter and full year ended December 31, 2019.

Trinseo, a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, announced that its Board of Directors authorized a quarterly dividend of $0.40 per share.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company committed to being the leader in responsible pain management, confirmed the details of the year-end earnings call, previously announced on February 13, 2020.

Supernus Pharmaceuticals, Inc., a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced that the Company’s management will present an overview and update, as well as host investor meetings, at the 40th Annual Cowen Health Care Conference.